Literature DB >> 21948097

Repeated integration of antibody genes into a pre-selected chromosomal locus of CHO cells using an accumulative site-specific gene integration system.

Yoshinori Kawabe1, Hirokatsu Makitsubo, Yujiro Kameyama, Shuohao Huang, Akira Ito, Masamichi Kamihira.   

Abstract

We previously reported an accumulative site-specific gene integration system using Cre recombinase and mutated loxP sites, where a recombinase-mediated cassette exchange (RMCE) reaction is repeatable. This gene integration system was applied for antibody production using recombinant Chinese hamster ovary (CHO) cells. We introduced an exchange cassette flanked by wild-type and mutated loxP sites into the chromosome of CHO cells for the establishment of recipient founder cells. Then, the donor plasmids including an expression cassette for an antibody gene flanked by a compatible pair of loxP sites were prepared. The donor plasmid and a Cre expression vector were co-transfected into the founder CHO cells to give rise to RMCE in the CHO genome, resulting in site-specific integration of the antibody gene. The RMCE procedure was repeated to increase the copy numbers of the integrated gene. Southern blot and genomic PCR analyses for the established cells revealed that the transgenes were integrated into the target site. Antibody production determined by ELISA and western blotting was increased corresponding to the number of transgenes. These results indicate that the accumulative site-specific gene integration system could provide a useful tool for increasing the productivity of recombinant proteins.

Entities:  

Year:  2011        PMID: 21948097      PMCID: PMC3386388          DOI: 10.1007/s10616-011-9397-y

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  38 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Construction of engineered CHO strains for high-level production of recombinant proteins.

Authors:  M Kito; S Itami; Y Fukano; K Yamana; T Shibui
Journal:  Appl Microbiol Biotechnol       Date:  2002-10-18       Impact factor: 4.813

3.  Utilization of site-specific recombination for generating therapeutic protein producing cell lines.

Authors:  Margie Campbell; Susanne Corisdeo; Clair McGee; Denny Kraichely
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

Review 4.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

Review 5.  Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells.

Authors:  Ted H J Kwaks; Arie P Otte
Journal:  Trends Biotechnol       Date:  2006-02-07       Impact factor: 19.536

Review 6.  25 years of recombinant proteins from reactor-grown cells - where do we go from here?

Authors:  David L Hacker; Maria De Jesus; Florian M Wurm
Journal:  Biotechnol Adv       Date:  2009-05-20       Impact factor: 14.227

7.  A dominant chromatin-opening activity in 5' hypersensitive site 3 of the human beta-globin locus control region.

Authors:  J Ellis; K C Tan-Un; A Harper; D Michalovich; N Yannoutsos; S Philipsen; F Grosveld
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

8.  Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system.

Authors:  Hong Zhou; Zhi-Gang Liu; Zhi-Wei Sun; Ying Huang; Wei-Yuan Yu
Journal:  J Biotechnol       Date:  2010-04-03       Impact factor: 3.307

9.  High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector.

Authors:  Masamichi Kamihira; Ken-ichiro Ono; Kazuhisa Esaka; Ken-ichi Nishijima; Ryoko Kigaku; Hiroyuki Komatsu; Takashi Yamashita; Kenji Kyogoku; Shinji Iijima
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Production of chimeric monoclonal antibodies by genetically manipulated chickens.

Authors:  Masamichi Kamihira; Yoshinori Kawabe; Takuya Shindo; Ken-ichiro Ono; Kazuhisa Esaka; Takashi Yamashita; Ken-ichi Nishijima; Shinji Iijima
Journal:  J Biotechnol       Date:  2009-03-17       Impact factor: 3.307

View more
  5 in total

1.  Genome sequence comparison between Chinese hamster ovary (CHO) DG44 cells and mouse using end sequences of CHO BAC clones based on BAC-FISH results.

Authors:  Shuichi Kimura; Takeshi Omasa
Journal:  Cytotechnology       Date:  2018-07-09       Impact factor: 2.058

2.  Rational design and construction of multi-copy biomanufacturing islands in mammalian cells.

Authors:  Raffaele Altamura; Jiten Doshi; Yaakov Benenson
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

3.  Homologous Recombination-Independent Large Gene Cassette Knock-in in CHO Cells Using TALEN and MMEJ-Directed Donor Plasmids.

Authors:  Tetsushi Sakuma; Mitsumasa Takenaga; Yoshinori Kawabe; Takahiro Nakamura; Masamichi Kamihira; Takashi Yamamoto
Journal:  Int J Mol Sci       Date:  2015-10-09       Impact factor: 5.923

4.  Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy.

Authors:  Felix Hart; Antje Danielczyk; Steffen Goletz
Journal:  Bioengineering (Basel)       Date:  2017-05-08

5.  Amplification of a transgene within a long array of replication origins favors higher gene expression in animal cells.

Authors:  Kiwamu Ohsaki; Yusuke Ohgaki; Noriaki Shimizu
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.